Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Biovest International Inc.

Division of Accentia Biopharmaceuticals Inc.
www.biovest.com

Latest From Biovest International Inc.

In Europe, A Public-Private Effort Could Shed Light On The Tricky Business Of Cancer Vaccines

With EU cash in hand, the GAPVAC consortium aims to develop tailor-made vaccines for patients with the rare but aggressive brain cancer, glioblastoma. The vaccines will be unique to each individual, but hopefully with increased efficacy compared with other therapies, thereby justifying the likely higher cost and complexity of treatment.

BioPharmaceutical Europe

New EU-Funded Consortium Aims To Develop Targeted Cancer Vaccines

A clinical trial is expected to start in the U.S. and Europe in 2014 of an individualized approach to developing a cancer vaccine for glioblastoma patients.

BioPharmaceutical Europe

Sign Of The Times: Late-Stage Cancer Vaccines On Display At ASCO

Vindicated by the approvals of Provenge and Yervoy, a host of therapeutic cancer vaccines is working through late-stage trials with the regulatory finish line in sight, and some of those companies will be presenting data at the American Society of Clinical Oncology meeting in Chicago June 1-5.

Clinical Trials Research & Development

Cancer Vaccines Headed For Mainstream

No longer the odd cousins of traditional pharmaceutical applications, a host of therapeutic cancer vaccines is working through late-stage trials with real, life-extending data already reported and the potential to create a lot of action in the oncology sector.

BioPharmaceutical Clinical Trials
See All

Company Information

  • Industry
  • Biotechnology
  • In Vitro Diagnostics
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Cellex Biosciences Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Accentia Biopharmaceuticals Inc.
  • Senior Management
  • Carlos F Santos, CEO
    James McNulty, CFO
  • Contact Info
  • Biovest International Inc.
    Phone: (508) 793-0001
    377 Plantation St.
    Biotech Bldg. 4
    Worcester, MA 01605
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register